FitLife Brands (FTLF) Competitors $13.64 -0.82 (-5.67%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$13.72 +0.07 (+0.55%) As of 05/16/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTLF vs. VECT, SION, KROS, IMTX, COGT, TYRA, VALN, MRVI, RLAY, and GHRSShould you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include VectivBio (VECT), Sionna Therapeutics (SION), Keros Therapeutics (KROS), Immatics (IMTX), Cogent Biosciences (COGT), Tyra Biosciences (TYRA), Valneva (VALN), Maravai LifeSciences (MRVI), Relay Therapeutics (RLAY), and GH Research (GHRS). These companies are all part of the "pharmaceutical products" industry. FitLife Brands vs. VectivBio Sionna Therapeutics Keros Therapeutics Immatics Cogent Biosciences Tyra Biosciences Valneva Maravai LifeSciences Relay Therapeutics GH Research VectivBio (NASDAQ:VECT) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, community ranking, risk, media sentiment, valuation, dividends and profitability. Does the MarketBeat Community believe in VECT or FTLF? VectivBio received 7 more outperform votes than FitLife Brands when rated by MarketBeat users. However, 60.00% of users gave FitLife Brands an outperform vote while only 43.48% of users gave VectivBio an outperform vote. CompanyUnderperformOutperformVectivBioOutperform Votes1043.48% Underperform Votes1356.52% FitLife BrandsOutperform Votes360.00% Underperform Votes240.00% Do analysts recommend VECT or FTLF? FitLife Brands has a consensus target price of $20.50, suggesting a potential upside of 50.29%. Given FitLife Brands' stronger consensus rating and higher possible upside, analysts clearly believe FitLife Brands is more favorable than VectivBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VectivBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00FitLife Brands 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has more risk and volatility, VECT or FTLF? VectivBio has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Does the media refer more to VECT or FTLF? In the previous week, FitLife Brands had 7 more articles in the media than VectivBio. MarketBeat recorded 7 mentions for FitLife Brands and 0 mentions for VectivBio. FitLife Brands' average media sentiment score of 0.11 beat VectivBio's score of 0.00 indicating that FitLife Brands is being referred to more favorably in the news media. Company Overall Sentiment VectivBio Neutral FitLife Brands Neutral Do insiders and institutionals believe in VECT or FTLF? 2.3% of FitLife Brands shares are owned by institutional investors. 9.7% of VectivBio shares are owned by insiders. Comparatively, 61.3% of FitLife Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is VECT or FTLF more profitable? FitLife Brands has a net margin of 13.38% compared to VectivBio's net margin of 0.00%. FitLife Brands' return on equity of 28.03% beat VectivBio's return on equity.Company Net Margins Return on Equity Return on Assets VectivBioN/A N/A N/A FitLife Brands 13.38%28.03%15.13% Which has better earnings & valuation, VECT or FTLF? FitLife Brands has higher revenue and earnings than VectivBio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVectivBio$27.34M20.97-$93.74MN/AN/AFitLife Brands$64.47M1.99$5.30M$0.8416.24 SummaryFitLife Brands beats VectivBio on 15 of the 17 factors compared between the two stocks. Get FitLife Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTLF vs. The Competition Export to ExcelMetricFitLife BrandsMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$128.00M$1.22B$5.36B$8.52BDividend YieldN/AN/A4.94%4.11%P/E Ratio16.1411.4227.0220.04Price / Sales1.998.76390.48119.72Price / Cash19.0510.4038.2534.62Price / Book4.491.446.764.60Net Income$5.30M-$56.07M$3.23B$248.70M7 Day Performance-12.51%2.56%4.83%5.15%1 Month Performance2.25%22.35%9.88%14.04%1 Year Performance-1.69%-36.66%15.35%6.76% FitLife Brands Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTLFFitLife Brands4.5016 of 5 stars$13.64-5.7%$20.50+50.3%-1.7%$128.00M$64.47M16.1420News CoverageEarnings ReportVECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030High Trading VolumeSIONSionna TherapeuticsN/A$12.90+4.7%$38.50+198.4%N/A$569.20MN/A0.0035News CoverageEarnings ReportKROSKeros Therapeutics3.0484 of 5 stars$13.74+0.7%$37.00+169.3%-73.1%$558.05M$214.71M-2.64100IMTXImmatics2.8503 of 5 stars$4.56+7.5%$16.67+265.5%-56.8%$554.27M$155.84M-6.91260News CoveragePositive NewsEarnings ReportAnalyst RevisionGap UpCOGTCogent Biosciences2.4241 of 5 stars$5.13+6.7%$14.29+178.5%-34.4%$547.65MN/A-2.0780Positive NewsTYRATyra Biosciences1.713 of 5 stars$10.26+1.7%$30.83+200.5%-45.3%$544.70MN/A-6.3720News CoveragePositive NewsVALNValneva2.3525 of 5 stars$6.45-0.3%$15.50+140.3%-28.6%$539.45M$169.58M-49.62700MRVIMaravai LifeSciences4.1184 of 5 stars$2.12+7.1%$6.34+199.2%-81.4%$539.19M$259.19M-1.29610Earnings ReportAnalyst ForecastOptions VolumeRLAYRelay Therapeutics3.3599 of 5 stars$3.11+3.7%$17.67+468.1%-57.7%$533.19M$7.68M-1.19330Positive NewsGHRSGH Research2.5744 of 5 stars$10.16-2.1%$30.43+199.5%-12.9%$528.60MN/A-12.8610News CoverageAnalyst UpgradeAnalyst Revision Related Companies and Tools Related Companies VectivBio Competitors Sionna Therapeutics Competitors Keros Therapeutics Competitors Immatics Competitors Cogent Biosciences Competitors Tyra Biosciences Competitors Valneva Competitors Maravai LifeSciences Competitors Relay Therapeutics Competitors GH Research Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTLF) was last updated on 5/18/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Two drop-dead simple ways to play the gold boomIf you take a few minutes to check out the short research briefing Mark & I have put together, I’m confident y...Eagle Publishing | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FitLife Brands, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FitLife Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.